Bright Minds Biosciences (DRUG) Shares Outstanding (Weighted Average): 2020-2024
Historic Shares Outstanding (Weighted Average) for Bright Minds Biosciences (DRUG) over the last 5 years, with Sep 2024 value amounting to $4.5 million.
- Bright Minds Biosciences' Shares Outstanding (Weighted Average) rose 20.47% to $2.4 million in Q3 2021 from the same period last year, while for Jun 2021 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is 18.34% up from last year.
- Latest data reveals that Bright Minds Biosciences reported Shares Outstanding (Weighted Average) of $4.5 million as of FY2024, which was up 18.34% from $3.8 million recorded in FY2023.
- In the past 5 years, Bright Minds Biosciences' Shares Outstanding (Weighted Average) ranged from a high of $4.5 million in FY2024 and a low of $2.0 million during FY2020.
- Its 3-year average for Shares Outstanding (Weighted Average) is $3.5 million, with a median of $3.8 million in 2023.
- Data for Bright Minds Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY soared of 58.87% (in 2023) over the last 5 years.
- Bright Minds Biosciences' Shares Outstanding (Weighted Average) (Yearly) stood at $2.0 million in 2020, then increased by 20.47% to $2.4 million in 2021, then rose by 0.32% to $2.4 million in 2022, then soared by 58.87% to $3.8 million in 2023, then grew by 18.34% to $4.5 million in 2024.